Axicabtagene Ciloleucel Outperforms Conventional First-Line Therapy
In a groundbreaking comparative study published in BMC Cancer, researchers have provided compelling evidence demonstrating the superiority of axicabtagene ciloleucel ...
In a groundbreaking comparative study published in BMC Cancer, researchers have provided compelling evidence demonstrating the superiority of axicabtagene ciloleucel ...
In a groundbreaking discovery that could reshape the landscape of lymphoma treatment, Australian scientists have unveiled a critical cellular mechanism ...
Relapsed and refractory peripheral and cutaneous T-cell lymphomas (R/R PTCL and CTCL) present some of the most formidable challenges within ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine